Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK-positive locally advanced or metastatic ...

Researchers have developed a method to program immune cells to target glioblastoma and reduce inflammation associated with ...

Researchers have created a "molecular GPS" to guide immune cells directly to the brain, enabling precise targeting of tumors ...

In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection ...

July 30, 2024 — A new study finds that giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

Researchers have found a way to program immune cells to attack glioblastoma and treat the inflammation of multiple sclerosis in mice.

Scientists have developed a 'molecular GPS' to guide immune cells into the brain and kill tumors without harming healthy tissue.